Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Kengreal patents expiration
Fortaz patents expiration
Septocaine patents expiration
Drugs that contains Belzutifan
Tiazac patents expiration
Johnson Johnson Visn patents expiration